TCL Archive ASSIST Gets Extra Year Of Funding While NCI Considers Role In Tobacco Control January 17, 1997
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers November 21, 1975
TCL Archive Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen December 31, 2004